These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6199966)

  • 1. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
    Ellis DW; Leffers S; Davies JS; Ng AB
    Am J Clin Pathol; 1984 Mar; 81(3):279-84. PubMed ID: 6199966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
    Arora B; Chhabra A; Yadav MS; Arora DR
    Indian J Pathol Microbiol; 1990 Jul; 33(3):235-8. PubMed ID: 1965432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of carcinoembryonic antigen in benign hyperplasia and adenocarcinoma of the prostate with monoclonal antibody.
    Ghazizadeh M; Kagawa S; Izumi K; Maebayashi K; Takigawa H; Saiki T; Kawano A; Kurokawa K
    J Urol; 1984 Mar; 131(3):501-3. PubMed ID: 6199524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W; Steffens J; Lobeck H; Blümcke S; Nagel R
    Eur Urol; 1985; 11(1):52-6. PubMed ID: 2580711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
    Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
    Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
    Sauvageot J; Epstein JI
    Prostate; 1998 Jan; 34(1):29-33. PubMed ID: 9428385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
    Shah NT; Tuttle SE; Strobel SL; Gandhi L
    J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of T antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate.
    Ghazizadeh M; Kagawa S; Izumi K; Kurokawa K
    J Urol; 1984 Dec; 132(6):1127-30. PubMed ID: 6209422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
    Svanholm H
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoperoxidase localization of prostate-specific antigen.
    Stein BS; Vangore S; Petersen RO; Kendall AR
    Am J Surg Pathol; 1982 Sep; 6(6):553-7. PubMed ID: 6183983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine needle aspiration biopsy.
    Katz RL; Raval P; Brooks TE; Ordóñez NG
    Diagn Cytopathol; 1985; 1(1):28-32. PubMed ID: 2424683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.
    McEntee M; Isaacs W; Smith C
    Prostate; 1987; 11(2):163-70. PubMed ID: 2444955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.